Literature DB >> 2163367

Effect of sodium azide on hydrogen peroxide production by zymosan-activated human neutrophils.

A Nahum1, M Hegarty, H Chen, W Chamberlin, J I Sznajder.   

Abstract

Stimulated neutrophils (PMNs) produce large quantities of superoxide anion, which is the precursor for hydrogen peroxide (H2O2). We developed a new fluorimetric assay to measure the H2O2 released by zymosan A-activated PMNs utilizing the oxidation of p-hydroxyphenylacetic acid by H2O2 to its fluorescent dimer in the presence of horseradish peroxidase. Zymosan-activated PMNs isolated from nine healthy volunteers and 20 patients with acute hypoxemic respiratory failure (AHRF) released after 90 min 2.3 +/- 0.3 and 2.4 +/- 1.3 nmol H2O2/10(6) PMNs, respectively. Inhibition of the heme enzymes by 1.0 mM sodium azide (NaN3) increased the H2O2 production to 21.6 +/- 4.4 nmol H2O2/10(6) PMNs in the control group (P less than 0.001), and to 22.5 +/- 14.7 nmol H2O2/10(6) PMNs in patients with AHRF (P less than 0.001). Incubation temperature, room temperature or 37 degrees C, did not change the total amount of H2O2 produced after 90 min by zymosan-activated PMN. Addition of NaN3 improved both the sensitivity and reproducibility of the measurement of H2O2 and allowed detection of H2O2 released by PMNs with coefficients of variation of less than 5% at PMN concentrations as low as 0.1 x 10(6) cells/ml. The amount of H2O2 released by activated PMNs did not distinguish healthy controls from patients with AHRF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2163367     DOI: 10.1007/BF00915813

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  28 in total

1.  Purification of horse-radish peroxidase and comparison of its properties with those of catalase and methaemoglobin.

Authors:  D KEILIN; E F HARTREE
Journal:  Biochem J       Date:  1951-06       Impact factor: 3.857

2.  The role of the phagocyte in host-parasite interactions. 13. The direct quantitative estimation of H2O2 in phagocytizing cells.

Authors:  B Paul; A J Sbarra
Journal:  Biochim Biophys Acta       Date:  1968-02-01

3.  New substrates for the fluorometric determination of oxidative enzymes.

Authors:  G G Guilbault; P J Brignac; M Juneau
Journal:  Anal Chem       Date:  1968-07       Impact factor: 6.986

4.  Oxygen radical production by neutrophils from patients with bacterial infection and rheumatoid arthritis. Measurement of hydrogen peroxide may most accurately represent enhancement of oxygen radical production during infection.

Authors:  Y Ozaki; T Ohashi; Y Niwa
Journal:  Inflammation       Date:  1986-06       Impact factor: 4.092

5.  Patients with adult respiratory distress syndrome (ARDS) demonstrate in vivo neutrophil activation associated with diminished binding of neutrophil-specific monoclonal antibody 31D8.

Authors:  M P Fletcher; M J Vassar; J W Holcroft
Journal:  Inflammation       Date:  1988-10       Impact factor: 4.092

6.  Production of hydrogen peroxide by phagocytizing human granulocytes.

Authors:  J W Homan-Müller; R S Weening; D Roos
Journal:  J Lab Clin Med       Date:  1975-02

7.  Quantitative and temporal characterization of the extracellular H2O2 pool generated by human neutrophils.

Authors:  S T Test; S J Weiss
Journal:  J Biol Chem       Date:  1984-01-10       Impact factor: 5.157

8.  Role of myeloperoxidase in the respiratory burst of human neutrophils.

Authors:  W M Nauseef; J A Metcalf; R K Root
Journal:  Blood       Date:  1983-03       Impact factor: 22.113

9.  H2O2 release from human granulocytes during phagocytosis. Relationship to superoxide anion formation and cellular catabolism of H2O2: studies with normal and cytochalasin B-treated cells.

Authors:  R K Root; J A Metcalf
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

10.  Chemiluminescence detection of H2O2 produced by human neutrophils during the respiratory burst.

Authors:  M P Wymann; V von Tscharner; D A Deranleau; M Baggiolini
Journal:  Anal Biochem       Date:  1987-09       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.